{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:43:26Z","timestamp":1773297806026,"version":"3.50.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.14310\/horm.2002.1200","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T12:10:43Z","timestamp":1390997443000},"page":"205-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Dysfunction of the Hypothalamic-Pituitary-Adrenal axis in HIV infection and disease"],"prefix":"10.1007","volume":"7","author":[{"given":"Evangelia","family":"Zapanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Terzidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Chrousos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,1]]},"reference":[{"key":"7030205_CR1","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","volume":"332","author":"GP Chrousos","year":"1995","unstructured":"Chrousos GP, 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332: 1351\u20131362.","journal-title":"N Engl J Med"},{"key":"7030205_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/138032a0","volume":"138","author":"H Selye","year":"1936","unstructured":"Selye H, 1936 A Syndrome Produced by Diverse Nocuous Agents. Nature 138: 32.","journal-title":"Nature"},{"key":"7030205_CR3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/jama.1992.03480090092034","volume":"267","author":"GP Chrousos","year":"1992","unstructured":"Chrousos GP, Gold PW, 1992 The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267: 1244\u20131252.","journal-title":"JAMA"},{"key":"7030205_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1210\/endo-110-1-272","volume":"110","author":"C Rivier","year":"1982","unstructured":"Rivier C, Brownstein M, Spiess J, Rivier J, Vale W, 1982 In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology 110: 272\u2013278.","journal-title":"Endocrinology"},{"key":"7030205_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1210\/jcem-58-3-463","volume":"58","author":"JV Conaglen","year":"1984","unstructured":"Conaglen JV, Donald RA, Espiner EA, Livesey JH, Nicholls MG, 1984 The effect of ovine corticotropin-releasing factor on catecholamine, vasopressin, and aldosterone secretion in normal man. J Clin Endocrinol Metab 58: 463\u2013466.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1749-6632.1995.tb44700.x","volume":"1771","author":"G Mastorakos","year":"1995","unstructured":"Mastorakos G, Magiakou MA, Chrousos GP, 1995 Effects of the immune\/inflammatory reaction on the hypothalamic-pituitary-adrenal axis. Ann N Y Acad Sci 1771: 438\u2013448.","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl1","key":"7030205_CR7","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1530\/eje.1.02243","volume":"155","author":"G Mastorakos","year":"2006","unstructured":"Mastorakos G, Karoutsou EI, Mizamtsidi M, 2006 Corticotropin releasing hormone and the immune\/inflammatory response Eur J Endocrinol 155: Suppl 1: S77\u2013S84","journal-title":"Eur J Endocrinol"},{"issue":"Suppl2","key":"7030205_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s003930070023","volume":"59","author":"G Mastorakos","year":"2000","unstructured":"Mastorakos G, Ilias I, 2000 Relationship between interleukin-6 (IL-6) and hypothalamic-pituitary-adrenal axis hormones in rheumatoid arthritis. Z Rheumatol 59: Suppl 2: 75\u201379.","journal-title":"Z Rheumatol"},{"key":"7030205_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2265.1991.tb03506.x","volume":"35","author":"H Imura","year":"1991","unstructured":"Imura H, Fukata J, Mori T, 1991 Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clin Endocrinol (Oxf) 35: 107\u2013115.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7030205_CR10","first-page":"1690","volume":"77","author":"G Mastorakos","year":"1993","unstructured":"Mastorakos G, Chrousos GP, Weber JS, 1993 Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77: 1690\u20131694.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR11","first-page":"934","volume":"79","author":"G Mastorakos","year":"1994","unstructured":"Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP, 1994 Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab 79: 934\u2013939.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR12","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.4049\/jimmunol.151.7.3460","volume":"151","author":"JC Kam","year":"1993","unstructured":"Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY, 1993 Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 151: 3460\u20133466.","journal-title":"J Immunol"},{"key":"7030205_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1530\/eje.0.1330173","volume":"133","author":"A Biglino","year":"1995","unstructured":"Biglino A, Limone P, Forno B et al, 1995 Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection. Eur J Endocrinol 133: 173\u2013179.","journal-title":"Eur J Endocrinol"},{"key":"7030205_CR14","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/00007611-198812000-00007","volume":"81","author":"CW Hilton","year":"1988","unstructured":"Hilton CW, Harrington PT, Prasad C, Svec F, 1988 Adrenal insufficiency in the acquired immunodeficiency syndrome. South Med J 81: 1493\u20131495.","journal-title":"South Med J"},{"key":"7030205_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/00002030-199106000-00013","volume":"5","author":"F Raffi","year":"1991","unstructured":"Raffi F, Brisseau JM, Planchon B, Remi JP, Barrier JH, Grolleau JY, 1991 Endocrine function in 98 HIV-infected patients: a prospective study. AIDS 5: 729\u2013733.","journal-title":"AIDS"},{"key":"7030205_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0002-9343(88)90144-1","volume":"84","author":"AS Dobs","year":"1988","unstructured":"Dobs AS, Dempsey MA, Ladenson PW, Polk BF, 1988 Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 84: 611\u2013616.","journal-title":"Am J Med"},{"key":"7030205_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1530\/acta.0.1210633","volume":"121","author":"B Verges","year":"1989","unstructured":"Verges B, Chavanet P, Desgres J et al, 1989 Adrenal function in HIV infected patients. Acta Endocrinol (Copenh) 121: 633\u2013637.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"7030205_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1210\/jcem-70-3-572","volume":"70","author":"JM Villette","year":"1990","unstructured":"Villette JM, Bourin P, Doinel C, et al, 1990 Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab 70: 572\u2013577.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1210\/jcem-65-3-482","volume":"65","author":"L Membreno","year":"1987","unstructured":"Membreno L, Irony I, Dere W, Klein R, Biglieri EG, Cobb E, 1987 Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 65: 482\u2013487.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1043-2760(97)00050-7","volume":"8","author":"PU Freda","year":"1997","unstructured":"Freda PU, Papadopoulos AD, Wardlaw SL, Goland RS, 1997 Spectrum of Adrenal Dysfunction in Patients with Acquired Immunodeficiency Syndrome \u2014 Evaluation of Adrenal and Pituitary Reserve with ACTH and Corticotropin-Releasing Hormone Testing. Trends Endocrinol Metab 8: 173\u2013180.","journal-title":"Trends Endocrinol Metab"},{"key":"7030205_CR21","first-page":"1091","volume":"79","author":"JW Findling","year":"1994","unstructured":"Findling JW, Buggy BP, Gilson IH, Brummitt CF, Bernstein BM, Raff H, 1994 Longitudinal evaluation of adrenocortical function in patients infected with the human immunodeficiency virus. J Clin Endocrinol Metab 79: 1091\u20131096.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR22","first-page":"220","volume":"2","author":"TH Schurmeyer","year":"1997","unstructured":"Schurmeyer TH, Muller V, von Zur MA, Schmidt RE, 1997 Thyroid and adrenal function in HIV-infected outpatients. Eur J Med Res 2: 220\u2013226.","journal-title":"Eur J Med Res"},{"key":"7030205_CR23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0165-0173(97)00041-6","volume":"26","author":"J Raber","year":"1998","unstructured":"Raber J, Sorg O, Horn TF, et al, 1998 Inflammatory cytokines: putative regulators of neuronal and neuroendocrine function. Brain Res Brain Res Rev 26: 320\u2013326.","journal-title":"Brain Res Brain Res Rev"},{"key":"7030205_CR24","first-page":"4373","volume":"83","author":"FB Hashemi","year":"1998","unstructured":"Hashemi FB, Hughes TK, Smith EM, 1998 Human immunodeficiency virus induction of corticotropin in lymphoid cells. J Clin Endocrinol Metab 83: 4373\u20134381.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1006\/exnr.2000.7502","volume":"166","author":"A Costa","year":"2000","unstructured":"Costa A, Nappi RE, Polatti F, Poma A, Grossman AB, Nappi G, 2000 Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide. Exp Neurol 166: 376\u2013384.","journal-title":"Exp Neurol"},{"key":"7030205_CR26","first-page":"608","volume":"74","author":"G Norbiato","year":"1992","unstructured":"Norbiato G, Bevilacqua M, Vago T, et al, 1992 Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 74: 608\u2013613.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1084\/jem.181.1.33","volume":"181","author":"DY Leung","year":"1995","unstructured":"Leung DY, Martin RJ, Szefler SJ, et al, 1995 Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 181: 33\u201340.","journal-title":"J Exp Med"},{"key":"7030205_CR28","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.186.9.1567","volume":"186","author":"DY Leung","year":"1997","unstructured":"Leung DY, Hamid Q, Vottero A, et al, 1997 Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med 186: 1567\u20131574.","journal-title":"J Exp Med"},{"key":"7030205_CR29","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1172\/JCI117943","volume":"95","author":"CM Bamberger","year":"1995","unstructured":"Bamberger CM, Bamberger AM, de Castro M, Chrousos GP, 1995 Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95: 2435\u20132441.","journal-title":"J Clin Invest"},{"key":"7030205_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1210\/me.2004-0112","volume":"19","author":"E Charmandari","year":"2005","unstructured":"Charmandari E, Chrousos GP, Ichijo T, et al, 2005 The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes. Mol Endocrinol 19: 52\u201364.","journal-title":"Mol Endocrinol"},{"key":"7030205_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0272-6386(12)80779-7","volume":"16","author":"FD Seney Jr","year":"1990","unstructured":"Seney FD Jr, Burns DK, Silva FG, 1990 Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis 16: 1\u201313.","journal-title":"Am J Kidney Dis"},{"key":"7030205_CR32","first-page":"518","volume":"17","author":"DE Sellmeyer","year":"1996","unstructured":"Sellmeyer DE, Grunfeld C, 1996 Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev 17: 518\u2013532.","journal-title":"Endocr Rev"},{"key":"7030205_CR33","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1097\/00002030-199909100-00031","volume":"13","author":"RB Stricker","year":"1999","unstructured":"Stricker RB, Goldberg DA, Hu C, Hsu JW, Goldberg B, 1999 A syndrome resembling primary aldosteronism (Conn syndrome) in untreated HIV disease. AIDS 13: 1791\u20131792.","journal-title":"AIDS"},{"key":"7030205_CR34","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1056\/NEJM199211053271906","volume":"327","author":"SK Grinspoon","year":"1992","unstructured":"Grinspoon SK, Bilezikian JP, 1992 HIV disease and the endocrine system. N Engl J Med 327: 1360\u20131365.","journal-title":"N Engl J Med"},{"key":"7030205_CR35","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1210\/jcem-60-5-947","volume":"60","author":"LN Parker","year":"1985","unstructured":"Parker LN, Levin ER, Lifrak ET, 1985 Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 60: 947\u2013952.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR36","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1210\/jcem-56-4-668","volume":"56","author":"B Zumoff","year":"1983","unstructured":"Zumoff B, Walsh BT, Katz JL, et al, 1983 Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa: a second hormonal parameter of ontogenic regression. J Clin Endocrinol Metab 56: 668\u2013672.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR37","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1210\/jcem.86.9.7843","volume":"86","author":"S Grinspoon","year":"2001","unstructured":"Grinspoon S, Corcoran C, Stanley T, Rabe J, Wilkie S, 2001 Mechanisms of androgen deficiency in human immunodeficiency virus-infected women with the wasting syndrome. J Clin Endocrinol Metab 86: 4120\u20134126.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR38","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1210\/jcem-56-4-668","volume":"56","author":"B Zumoff","year":"1983","unstructured":"Zumoff B, Walsh BT, Katz JL, et al, 1983 Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa: a second hormonal parameter of ontogenic regression. J Clin Endocrinol Metab 56: 668\u2013672.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000441-199302000-00003","volume":"305","author":"TL Wisniewski","year":"1993","unstructured":"Wisniewski TL, Hilton CW, Morse EV, Svec F, 1993 The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness. Am J Med Sci 305: 79\u201383.","journal-title":"Am J Med Sci"},{"issue":"Suppl1","key":"7030205_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0306-4530(97)00015-2","volume":"22","author":"N Christeff","year":"1997","unstructured":"Christeff N, Gherbi N, Mammes O, et al, 1997 Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology 22: Suppl 1: 11\u201318.","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl1","key":"7030205_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0306-4530(97)00019-X","volume":"22","author":"M Clerici","year":"1997","unstructured":"Clerici M, Trabattoni D, Piconi S, et al, 1997 A possible role for the cortisol\/anticortisols imbalance in the progression of human immunodeficiency virus. Psycho-neuroendocrinology 22: Suppl 1: 27\u201331","journal-title":"Psycho-neuroendocrinology"},{"key":"7030205_CR42","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/infdis\/167.4.830","volume":"167","author":"BA Araneo","year":"1993","unstructured":"Araneo BA, Woods ML, Daynes RA, 1993 Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis 167: 830\u2013840.","journal-title":"J Infect Dis"},{"key":"7030205_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00000441-200102000-00005","volume":"321","author":"MS Eledrisi","year":"2001","unstructured":"Eledrisi MS, Verghese AC, 2001 Adrenal insufficiency in HIV infection: a review and recommendations. Am J Med Sci 321: 137\u2013144.","journal-title":"Am J Med Sci"},{"key":"7030205_CR44","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1699-0463.1988.tb00956.x","volume":"96","author":"YS Salim","year":"1988","unstructured":"Salim YS, Faber V, Wiik A, Andersen PL, Hoier-Madsen M, Mouritsen S, 1988 Anti-corticosteroid antibodies in AIDS patients. APMIS 96: 889\u2013894.","journal-title":"APMIS"},{"key":"7030205_CR45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/s-2007-978903","volume":"30","author":"P Putignano","year":"1998","unstructured":"Putignano P, Kaltsas GA, Satta MA, Grossman AB, 1998 The effects of anti-convulsant drugs on adrenal function. Horm Metab Res 30: 389\u2013397.","journal-title":"Horm Metab Res"},{"key":"7030205_CR46","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1210\/jcem-59-6-1204","volume":"59","author":"V Kyriazopoulou","year":"1984","unstructured":"Kyriazopoulou V, Parparousi O, Vagenakis AG, 1984 Rifampicin-induced adrenal crisis in addisonian patients receiving corticosteroid replacement therapy. J Clin Endocrinol Metab 59: 1204\u20131206.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/pgmj.64.751.405","volume":"64","author":"SK Ediger","year":"1988","unstructured":"Ediger SK, Isley WL, 1988 Rifampicin-induced adrenal insufficiency in the acquired immunodeficiency syndrome: difficulties in diagnosis and treatment. Postgrad Med J 64: 405\u2013406.","journal-title":"Postgrad Med J"},{"key":"7030205_CR48","doi-asserted-by":"publisher","first-page":"843","DOI":"10.7326\/0003-4819-122-11-199506010-00006","volume":"122","author":"MC Leinung","year":"1995","unstructured":"Leinung MC, Liporace R, Miller CH, 1995 Induction of adrenal suppression by megestrol acetate in patients with AIDS Ann Intern Med 122: 843\u2013845.","journal-title":"Ann Intern Med"},{"key":"7030205_CR49","first-page":"727","volume":"109","author":"GW Niedt","year":"1985","unstructured":"Niedt GW, Schinella RA, 1985 Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies. Arch Pathol Lab Med 109: 727\u2013734.","journal-title":"Arch Pathol Lab Med"},{"key":"7030205_CR50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.7326\/0003-4819-100-2-239","volume":"100","author":"ML Tapper","year":"1984","unstructured":"Tapper ML, Rotterdam HZ, Lerner CW, Al\u2019Khafaji K, Seitzman PA, 1984 Adrenal necrosis in the acquired immunodeficiency syndrome. Ann Intern Med 100: 239\u2013241.","journal-title":"Ann Intern Med"},{"key":"7030205_CR51","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jama.1984.03350090028018","volume":"252","author":"K Welch","year":"1984","unstructured":"Welch K, Finkbeiner W, Alpers CE, et al, 1984 Autopsy findings in the acquired immune deficiency syndrome. JAMA 252: 1152\u20131159.","journal-title":"JAMA"},{"key":"7030205_CR52","first-page":"323","volume":"38","author":"U Masharani","year":"1993","unstructured":"Masharani U, Schambelan M, 1993 The endocrine complications of acquired immunodeficiency syndrome. Adv Intern Med 38: 323\u2013336.","journal-title":"Adv Intern Med"},{"key":"7030205_CR53","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1001\/archinte.162.10.1095","volume":"162","author":"J Mayo","year":"2002","unstructured":"Mayo J, Collazos J, Martinez E, Ibarra S, 2002 Adrenal Function in the Human Immunodeficiency Virus-Infected Patient. Arch Intern Med 162: 1095\u20131098.","journal-title":"Arch Intern Med"},{"key":"7030205_CR54","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/00005792-199109000-00004","volume":"70","author":"R McKenzie","year":"1991","unstructured":"McKenzie R, Travis WD, Dolan SA, et al, 1991 The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases. Medicine (Baltimore) 70: 326\u2013343.","journal-title":"Medicine (Baltimore)"},{"key":"7030205_CR55","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(88)91624-8","volume":"1","author":"F Bricaire","year":"1988","unstructured":"Bricaire F, Marche C, Zoubi D, Regnier B, Saimot AG, 1988 Adrenocortical lesions and AIDS. Lancet 1: 881.","journal-title":"Lancet"},{"key":"7030205_CR56","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/00005792-199609000-00003","volume":"75","author":"LC Hofbauer","year":"1996","unstructured":"Hofbauer LC, Heufelder AE, 1996 Endocrine implications of human immunodeficiency virus infection. Medicine (Baltimore) 75: 262\u2013278.","journal-title":"Medicine (Baltimore)"},{"key":"7030205_CR57","first-page":"43","volume":"9","author":"PU Freda","year":"1999","unstructured":"Freda PU, Bilezikian JP, 1999 The hypothalamus-pituitary-adrenal axis in HIV disease. AIDS Read 9: 43\u201350.","journal-title":"AIDS Read"},{"key":"7030205_CR58","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.med.55.091902.104412","volume":"55","author":"P Koutkia","year":"2004","unstructured":"Koutkia P, Grinspoon S, 2004 HIV-Associated Lipodystrophy: Pathogenesis, Prognosis, Treatment, and Controversies. Annu Rev Med 55: 303\u2013317.","journal-title":"Annu Rev Med"},{"key":"7030205_CR59","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","volume":"357","author":"E Martinez","year":"2001","unstructured":"Martinez E, Mocroft A, Garcia-Viejo MA, et al, 2001 Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet 357: 592\u2013598.","journal-title":"Lancet"},{"key":"7030205_CR60","doi-asserted-by":"publisher","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Burton S, et al, 1998 A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12: F51\u2013F58.","journal-title":"AIDS"},{"key":"7030205_CR61","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1155\/2005\/303141","volume":"16","author":"JG Baril","year":"2005","unstructured":"Baril JG, Junod P, Leblanc R, et al, 2005 HIV-associated lipodystrophy syndrome: A review of clinical aspects. Can J Infect Dis Med Microbiol 16: 233\u2013243.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"7030205_CR62","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1086\/514638","volume":"27","author":"KK Miller","year":"1998","unstructured":"Miller KK, Daly PA, Sentochnik D, 1998 Pseudo-Cushing\u2019s syndrome in human immunodeficiency virus-infected patients. Clin Infect Dis 27: 68.","journal-title":"Clin Infect Dis"},{"key":"7030205_CR63","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1210\/jcem.84.6.5740","volume":"84","author":"JA Yanovski","year":"1999","unstructured":"Yanovski JA, Miller KD, Kino T, et al, 1999 Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy. J Clin Endocrinol Metab 84: 1925\u20131931.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR64","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","volume":"351","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Chisholm DJ, Cooper DA, 1998 Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351: 1881\u20131883.","journal-title":"Lancet"},{"key":"7030205_CR65","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1210\/jc.2002-020794","volume":"87","author":"D Chen","year":"2002","unstructured":"Chen D, Misra A, Garg A, 2002 Clinical review 153: Li-podystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 87: 4845\u20134856.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR66","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","volume":"354","author":"K Brinkman","year":"1999","unstructured":"Brinkman K, Smeitink JA, Romijn JA, Reiss P, 1999 Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354: 1112\u20131115.","journal-title":"Lancet"},{"key":"7030205_CR67","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1172\/JCI200215626","volume":"110","author":"GM Behrens","year":"2002","unstructured":"Behrens GM, Boerner AR, Weber K, et al, 2002 Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy. J Clin Invest 110: 1319\u20131327.","journal-title":"J Clin Invest"},{"key":"7030205_CR68","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1210\/jc.2002-020795","volume":"88","author":"CL Addy","year":"2003","unstructured":"Addy CL, Gavrila A, Tsiodras S, Brodovicz K, Karchmer AW, Mantzoros CS, 2003 Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab 88: 627\u2013636.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR69","doi-asserted-by":"publisher","first-page":"13432","DOI":"10.1073\/pnas.0704212104","volume":"104","author":"C Coffinier","year":"2007","unstructured":"Coffinier C, Hudon SE, Farber, et al, 2007 HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. Proc Natl Acad Sci USA 104: 13432\u201313437.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7030205_CR70","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1194\/jlr.M200487-JLR200","volume":"44","author":"H Tran","year":"2003","unstructured":"Tran H, Robinson S, Mikhailenko I, Strickland DK, 2003 Modulation of the LDL receptor and LRP levels by HIV protease inhibitors. J Lipid Res 44: 1859\u20131869.","journal-title":"J Lipid Res"},{"key":"7030205_CR71","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","volume":"359","author":"JP Bastard","year":"2002","unstructured":"Bastard JP, Caron M, Vidal H, et al, 2002 Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 359: 1026\u20131031.","journal-title":"Lancet"},{"key":"7030205_CR72","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/427697","volume":"40","author":"A Gavrila","year":"2005","unstructured":"Gavrila A, Hsu W, Tsiodras S, et al, 2005 Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2 \u00d7 2 factorial, randomized, double-blinded, placebo-controlled trial. Clin Infect Dis 40: 745\u2013749.","journal-title":"Clin Infect Dis"},{"key":"7030205_CR73","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1210\/jc.2005-1545","volume":"91","author":"J Lee","year":"2006","unstructured":"Lee J, Chan J, Sourlas E, Raptopoulos V, Mantzoros C, 2006 Recombinant Methionyl Human Leptin Therapy in Replacement Doses Improves Insulin Resistance and Metabolic Profile in Patients with Lipoatrophy and Metabolic Syndrome Induced by the Highly Active Antiretroviral Therapy J Clin Endocrinol Metab 91: 2605\u20132611.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR74","doi-asserted-by":"publisher","first-page":"9797","DOI":"10.1074\/jbc.M709629200","volume":"283","author":"C Coffinier","year":"2008","unstructured":"Coffinier C, Hudon S, Lee R, et al, 2008 A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells. J Biol Chem 283: 9797\u20139804.","journal-title":"J Biol Chem"},{"key":"7030205_CR75","first-page":"3260","volume":"82","author":"G Norbiato","year":"1997","unstructured":"Norbiato G, Bevilacqua M, Vago T, Taddei A, Clerici, 1997 Glucocorticoids and the immune function in the human immunodeficiency virus infection: a study in hypercortisolemic and cortisol-resistant patients. J Clin Endocrinol Metab 82: 3260\u20133263.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR76","first-page":"2601","volume":"81","author":"G Norbiato","year":"1996","unstructured":"Norbiato G, Bevilacqua M, Vago T, Clerici M, 1996 Glucocorticoids and interferon-alpha in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 81: 2601\u20132606.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR77","first-page":"1932","volume":"84","author":"C Hadigan","year":"1999","unstructured":"Hadigan C, Miller K, Corcoran C, Anderson E, Basgoz N, Grinspoon S, 1999 Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 84: 1932\u20131937.","journal-title":"J Clin Endocrinol Metab"},{"key":"7030205_CR78","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1212\/WNL.40.3_Part_1.535","volume":"40","author":"DM Simpson","year":"1990","unstructured":"Simpson DM, Bender AN, Farraye J, Mendelson SG, Wolfe DE, 1990 Human immunodeficiency virus wasting syndrome may represent a treatable myopathy. Neurology 40: 535\u2013538.","journal-title":"Neurology"},{"key":"7030205_CR79","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/QAD.0b013e328270356a","volume":"21","author":"TT Brown","year":"2007","unstructured":"Brown TT, Chu H, Wang Z, et al, 2007 Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy. AIDS 21: 1731\u20131738.","journal-title":"AIDS"},{"key":"7030205_CR80","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1677\/joe.0.1690437","volume":"169","author":"T Kino","year":"2001","unstructured":"Kino T, Chrousos GP, 2001 Glucocorticoid and min-eralocorticoid resistance\/hypersensitivity syndromes. J Endocrinol 169: 437\u2013445.","journal-title":"J Endocrinol"},{"key":"7030205_CR81","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/00002030-199907300-00004","volume":"13","author":"CA Wanke","year":"1999","unstructured":"Wanke CA, 1999 Epidemiological and clinical aspects of the metabolic complications of HIV infection the fat redistribution syndrome. AIDS 13: 1287\u20131293.","journal-title":"AIDS"},{"key":"7030205_CR82","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1196\/annals.1321.013","volume":"1024","author":"T Kino","year":"2004","unstructured":"Kino T, Chrousos GP, 2004 Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance\/lipodystrophy syndrome? Ann N Y Acad Sci 1024: 153\u2013167.","journal-title":"Ann N Y Acad Sci"},{"key":"7030205_CR83","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0960-9822(02)00676-0","volume":"6","author":"M Emerman","year":"1996","unstructured":"Emerman M, 1996 HIV-1, Vpr and the cell cycle. Curr Biol 6: 1096\u20131103.","journal-title":"Curr Biol"},{"key":"7030205_CR84","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1128\/JVI.79.5.2780-2787.2005","volume":"79","author":"T Kino","year":"2005","unstructured":"Kino T, Gragerov A, Valentin A, et al, 2005 Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest. J Virol 79: 2780\u20132787.","journal-title":"J Virol"},{"key":"7030205_CR85","doi-asserted-by":"publisher","first-page":"35209","DOI":"10.1074\/jbc.M005197200","volume":"275","author":"BE Sawaya","year":"2000","unstructured":"Sawaya BE, Khalili K, Gordon J, Taube R, Amini S, 2000 Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J Biol Chem 275: 35209\u201335214.","journal-title":"J Biol Chem"},{"key":"7030205_CR86","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1570162052772988","volume":"3","author":"JL Andersen","year":"2005","unstructured":"Andersen JL, Planelles V, 2005 The role of Vpr in HIV-1 pathogenesis. Curr HIV Res 3: 43\u201351.","journal-title":"Curr HIV Res"},{"key":"7030205_CR87","first-page":"45","volume-title":"AIDS: Diagnosis, Treatment and Prevention","author":"GN Pavlakis","year":"1996","unstructured":"Pavlakis GN 1996 The molecular biology of HIV-1. In: Devita VT, Hellman S, Rosenberg SA (eds) AIDS: Diagnosis, Treatment and Prevention. Lippincott Raven, Philadelphia; pp, 45\u201374."},{"key":"7030205_CR88","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1128\/jvi.69.2.1243-1252.1995","volume":"69","author":"DN Levy","year":"1995","unstructured":"Levy DN, Refaeli Y, Weiner DB, 1995 Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J Virol 69: 1243\u20131252.","journal-title":"J Virol"},{"key":"7030205_CR89","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1006\/viro.2002.1576","volume":"302","author":"MP Sherman","year":"2002","unstructured":"Sherman MP, Schubert U, Williams SA, et al, 2002 HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. Virology 302: 95\u2013105.","journal-title":"Virology"},{"key":"7030205_CR90","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.189.1.51","volume":"189","author":"T Kino","year":"1999","unstructured":"Kino T, Gragerov A, Kopp JB, Stauber RH, Pavlakis GN, Chrousos GP, 1999 The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J Exp Med 189: 51\u201362.","journal-title":"J Exp Med"},{"key":"7030205_CR91","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/42750","volume":"387","author":"DM Heery","year":"1997","unstructured":"Heery DM, Kalkhoven E, Hoare S, Parker MG, 1997 A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387: 733\u2013736.","journal-title":"Nature"},{"key":"7030205_CR92","doi-asserted-by":"publisher","first-page":"9724","DOI":"10.1128\/JVI.76.19.9724-9734.2002","volume":"76","author":"T Kino","year":"2002","unstructured":"Kino T, Gragerov A, Slobodskaya O, Tsopanomichalou M, Chrousos GP, Pavlakis GN, 2002 Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300\/CBP coactivators. J Virol 76: 9724\u20139734.","journal-title":"J Virol"},{"key":"7030205_CR93","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.4049\/jimmunol.169.11.6361","volume":"169","author":"M Mirani","year":"2002","unstructured":"Mirani M, Elenkov I, Volpi S, Hiroi N, Chrousos GP, Kino T, 2002 HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol 169: 6361\u20136368.","journal-title":"J Immunol"},{"key":"7030205_CR94","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/me.2007-0124","volume":"22","author":"S Shrivastav","year":"2008","unstructured":"Shrivastav S, Kino T, Cunningham T, et al, 2008 Human Immunodeficiency Virus (HIV-1) viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor \u03b3 and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy Mol Endocrinol 22: 234\u2013247.","journal-title":"Mol Endocrinol"},{"key":"7030205_CR95","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1073\/pnas.91.2.664","volume":"91","author":"S Fawell","year":"1994","unstructured":"Fawell S, Seery J, Daikh Y, et al, 1994 Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A 91: 664\u2013668.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7030205_CR96","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1074\/jbc.M106312200","volume":"277","author":"T Kino","year":"2002","unstructured":"Kino T, Slobodskaya O, Pavlakis GN, Chrousos GP, 2002 Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J Biol Chem 277: 2396\u20132405.","journal-title":"J Biol Chem"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1200\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:33:48Z","timestamp":1739115228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["7030205"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1200","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"27 June 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}